Tvardi Therapeutics (TVRD) Return on Sales [ROS] (2013 - 2025)
Tvardi Therapeutics (TVRD) reported Return on Sales [ROS] of -169.48% for Q1 2025, up 1220.03 percentage points from -1389.51% a year earlier and up 572.92 percentage points from the prior quarter.
Tvardi Therapeutics (TVRD) Return on Sales [ROS] (2013 - 2025) Analysis & Trends
Over the twelve months ended Mar 31, 2025, Tvardi Therapeutics' Return on Sales [ROS] came in at -370.00%, up 359.19 percentage points year-over-year; for FY2024, it came in at -393.82%, up 185.61 percentage points from FY2023.
- Return on Sales [ROS] has a five-year change of +167.78 percentage points (FY2019 to FY2024).
- By year, Return on Sales [ROS] came in at -579.43% in FY2023 (-370.35 pp), -209.08% in FY2022 (+177.77 pp), -386.85% in FY2021 (-390.83 pp) and 3.99% in FY2020 (+565.58 pp).
- The Q1 2025 figure ranks as the highest quarterly Return on Sales [ROS] since Q2 2022.
- Year over year, Return on Sales [ROS] has now increased in each of the last three quarters, with an average year-over-year change of -26.26 percentage points over the last eight quarters.
- The high point for year-over-year Return on Sales [ROS] in five years was Q4 2022 (a gain of 3123.03 percentage points); the low point was Q4 2021 (a drop of 4152.92 percentage points).
- Per Business Quant data, the three quarters before Q1 2025 came in at -742.41% (Q4 2024), -222.07% (Q3 2024) and -724.62% (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Tvardi Therapeutics | 13.23 Mn | -94.87 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -169.48% |
| Dec 31, 2024 | -742.41% |
| Sep 30, 2024 | -222.07% |
| Jun 30, 2024 | -724.62% |
| Mar 31, 2024 | -1,389.51% |
| Dec 31, 2023 | -1,085.45% |
| Sep 30, 2023 | -593.88% |
| Jun 30, 2023 | -466.46% |
| Mar 31, 2023 | -448.50% |
| Dec 31, 2022 | -960.04% |
| Sep 30, 2022 | -220.52% |
| Jun 30, 2022 | -19.44% |
| Mar 31, 2022 | -582.69% |
| Dec 31, 2021 | -4,083.07% |
| Sep 30, 2021 | -5.54% |
| Jun 30, 2021 | 5.54% |
| Mar 31, 2021 | -1,217.62% |
| Dec 31, 2020 | 69.85% |
| Sep 30, 2020 | -183.68% |
| Jun 30, 2020 | -459.42% |
Tvardi Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();